The Organization file

Merck

9 stories · 3 sources · updated every week

Merck's mRNA melanoma vaccine with Moderna cut recurrence risk in a 1,137-patient trial. This marks a major win for personalized mRNA cancer treatments. Watch for full data replication and regulatory filings for the 17,000 UK melanoma patients.

Timeline

Aug 31

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

CNBC

Aug 19

Moderna Stock Doubles on Merck Melanoma Vaccine Results

Google News Business

Aug 19

Trump to Nominate Overton as FDA Commissioner

STAT News

Aug 19

STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

STAT News

Aug 17

Dow loses more than 270 points as oil prices pressure stocks amid rising Iran tensions - CNBC

Google News Business

Aug 12

WHO, DRC advance Ebola vaccine trial as outbreak sets pace record

STAT News

Aug 11

Trump's MMR Split Would Undo Decades of Vaccine Success

STAT News

Jul 22

Study Backs Merck's Ervebo for Bundibugyo Ebola

STAT News

Jul 22

FDA Approves First Oral PCSK9 Inhibitor Enlicitide

STAT News

Jul 16

FDA Approves Merck's Lipfendra Cholesterol Pill

STAT News

Jul 14

STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year

STAT News

Jun 30

Honeywell Aerospace Starts Trading, Finishes 3-Way

Google News Business

Merck

Timeline

Moderna-Merck mRNA Melanoma Vaccine Gives Field a Boost

Senators Press RFK Jr. Over Gardasil Stake Disclosure

Moderna-Merck Cancer Vaccine Cuts Melanoma Recurrence Risk

Moderna-Merck Cancer Vaccine Breakthrough Draws Biotech AI Money

Moderna Stock Soars 177% on Merck Cancer Vaccine Win

Why Is Moderna Stock Down Today? - Forbes

STAT+: One of the most consequential years for cancer treatment, ever

Merck-Moderna mRNA Vaccine Cuts Melanoma Recurrence

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

Moderna Stock Doubles on Merck Melanoma Vaccine Results

Trump to Nominate Overton as FDA Commissioner

STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

Dow loses more than 270 points as oil prices pressure stocks amid rising Iran tensions - CNBC

WHO, DRC advance Ebola vaccine trial as outbreak sets pace record

Trump's MMR Split Would Undo Decades of Vaccine Success

Study Backs Merck's Ervebo for Bundibugyo Ebola

FDA Approves First Oral PCSK9 Inhibitor Enlicitide

FDA Approves Merck's Lipfendra Cholesterol Pill

STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year

Honeywell Aerospace Starts Trading, Finishes 3-Way

Shows up with